Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-384-1 | CAS number: 39255-32-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 March to 19 Apr 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed accoding to GLP, OECD Guidelines followed and no deviations reported
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Ethyl 2-methylvalerate
- EC Number:
- 254-384-1
- EC Name:
- Ethyl 2-methylvalerate
- Cas Number:
- 39255-32-8
- Molecular formula:
- C8H16O2
- IUPAC Name:
- ethyl 2-methylpentanoate
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): EMV (EMV correspond to Ethyl 2-methylvalerate)
- Expiration date of the lot/batch: 25 Jul 2014
- Storage condition of test material: Immediately upon receipt, the test item was registered, then stored at room temperature in accordance with the Sponsor’s instructions. The complete description of the chemical and physical properties of the test item including stability is the responsibility of the Sponsor.
- Other:
- Supplier: Toyo Gosei Co., Ltd.
- Intended use: Ind. Chemical
- On 12 Mar 2012, one sample of test item was received in vial labelled “Ethyl 2-methylvalerate(EMV) Batch No. H3-G-26”. The study monitor confirm that this test item correspond to “EMV Batch No. H3-G-26’’, name used in the study report.
- Handling instructions for test item: General safety procedures as appropriate for handling of chemicals of unknown hazard potential were applied. For further details about safety, see the material safety data sheet supplied with the test item by the Sponsor.
- Remaining test item: The remaining test item, except the sample to he archived, (in case of archiving of test item) will be sent to Laboservice, route de Ia Centrale, 69702, Givors Cedex, where it will he destroyed by incineration, under the responsibility of CERB.
- The certificate of analysis of test item is presented in Appendix A, page 28 of attached report.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: SPF (Specific Pathogen Free) Sprague-Dawley -Crl:OFA (SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratoires France - Domaine des Oncins, 69210 L’Arbresle Cedex.
- Age at study initiation: 9 weeks at the time of administration.
- Weight at study initiation: Within ± 20% of the mean weight of any previously dosed animals.
- Housing: Daily observations were undertaken at the time of delivery of the animals and during the period of acclimatisation. Animals were housed in groups of 5 at maximum, in cages of standard dimensions with sawdust bedding.
- Diet (e.g. ad libitum): Feeding: RM1 (E)-SQC SDS/DIETEX feed (quality controlled) was available ad libitum except during the fasting experimental period. The certificate of analysis concerning this feed product is included in Appendix B, page 30 of attached report. The criteria for acceptable levels of contaminant, in the feed supply were thin the limits of the analytical specifications established by the diet manufacturer.
- Water (e.g. ad libitum): Drinking water: Drinking water was available ad libitum in polvcarbonate bottles with a stainless steel nipple. A specimen of water is obtained approximately every 6 months and sent to the LAEASE Region Sud Est - 5, avenue Achille Maureau – B. P. 95 - 84703 Sorgues Cedex - France, for analysis. The certificate of analysis are included in Appendix C, page 32 of attached report. The criteria for acceptable levels of contaminants in the water supplied were within the limits of the analytical specifications.
- Acclimation period: Acclimatisation: Five days before treament in the laboratory animal house where the experiment took place.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24 - No deviations outside of the temperature or hygrometry ranges were reported by the Study Director according to the SOP 5.36.
- Humidity (%): Relative humidity between 45% and 65% (except during the cleaning slot)
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): The artificial day/night cycle involved 12 hours light and 12 hours darkness with light on at 7.30 am.
- Other:
- Identification: Animals were identified individually by marking the tail with a felt tip marker.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Justification for choice of vehicle: Corn oil was chosen after the solubility trial, on the basis of the physico-chemical characteristics of the test item
- Lot/batch no. (if required): SIGMA, Batch No. MKBF8603V, Expiry date: 5 Mar 2017
MAXIMUM DOSE VOLUME APPLIED: 10mL/kg
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: not provided - Doses:
- 2000 mg/kg.
- No. of animals per sex per dose:
- Female: 6 animals with 3 animals per step.
- Control animals:
- no
- Details on study design:
- Examination:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were weighed on the following days:
- on D1, day of administration
- on D4, D7, D10 and D14 during the study
- on D15, day of necropsy (not exsanguinated)
- Necropsy of survivors performed: yes - All animals surviving to the end of the 14-day monitoring period were euthanased on D15 by subtotal exsanguination, after isoflurane inhalation. All animals were subjected to gross necropsy and their organs (brain, liver, spleen, kidneys, stomach, intestines, gonads/reproductive tact, lungs and heart) were examined macroscopically.
- Other examinations performed:
- Mortality - Morbidity: Mortality was recorded twice a day, i.e. in the morning and at the end of the working day.
- Clinical signs:
- General examination: Animals were examined clinically once before dosing and twice on the day of treatment (30 minutes ± 2 minutes post-dose and then again between 3 and 4 hours post-dose). Thereafter they were examined clinically at least once a day for 14 days. The general disposition, behaviour and activity were observed (See Section 1, page 10 of attached report).
- Functional and neurobehavioural tests: On D1 (30 minutes ± 1 minutes post-dose), on D7 and on D14, animals were observed according to a standardised observation battery for general clinical signs, neurobehavioural, neurovegetative or psychotropic signs or neurotoxic effects. The method is based on the Irwin screen* modified by suppressing the graduation of intensity of clinical signs. Animals were observed individually in a cage with out sawdust in a quiet room. Clinical signs were observed according to Table 1.1, page 21 of attached report.
- Food and water consumption, fasted periods: Food and water consumption were not measured. Animals were fasted during the night before treatment and remain deprived of food for 3 to 4 hours post-dose.
- Pathology: Euthanasia were performed by CERB under the responsibility of P. Pradeau, DVM, AnatomopathoIogist.
- Method of administration:
- Timing, frequency and duration of administration: EMV was administered to animals deprived of food since the previous day. It was administered to the animals as a single dose, by gavage, using a cannuIa of appropriate size.
- Volume to be administered: The dose volume was 10 mL/kg.
* Irwin S. Comprehensive observational assessment: A ystematic quantitative procedure fo assessing the behavioural and physiological state of the mouse. Psychopharmacologica. 1968; 13:222-257.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- other: No deaths and no evidence of toxicity at 2000 mg/kg
- Mortality:
- MORTALITY: No mortality occurred during the study.
- Clinical signs:
- other: CLINICAL FINDINGS: There was no clinical sign during the study.
- Gross pathology:
- MACROSCOPIC FINDINGS: Individual data are presented in Table 2.5, page 26 of attached report. No findings were seen at necropsy.
Any other information on results incl. tables
DISCUSSION: Since the body weight change was minimal (at maximum -2%) and because body weight increased or remained stable in three other animals between D7 and D10 and in all animals on D14, this change was not attributed to an effect of the test item.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the experimental conditions adopted, EMV administered once by oral route in the Sprague Dawley rat at 2000 mg/kg did not induce any sign of toxicity.
- Executive summary:
The aim of this study was to determine the acute toxicity of EMV at 2000 mg/kg after single dose administration by the oral (gavage) route in the rat.
Experimental procedure:
- 6 animals were treated at 2000 mg/kg.
- Mortality was recorded twice a day for 14 days. Clinical observations were performed before the dosing then daily. Functional and neurobehavioural tests were performed on D1, D7 and D14.
- Body weight was recorded on D1, D4, D7, D10 and D14.
- Animals were subjected to gross necropsy on D15.
Results:
- Mortality: No mortality occurred during the study.
- Clinical signs: There was no clinical sign during the study.
- Body weight: There was no treatment-related change in body weight gain.
- Macroscopic examination: No findings were seen at necropsy.
Conclusion:
Under the experimental conditions adopted, EMV administered once by oral route in the Sprague Dawley rat at 2000 mg/kg did not induce any sign of toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.